ArticleJournal of computer-aided molecular design2025
Breast cancer diagnosis from histopathological images and molecular signatures by fusing features with an explainable AI-based residual tabular network model.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early Breast Cancer (BC) Diagnosis has the potential to cut BC death rates in the long term drastically. Identifying early-stage cancer cells is the most crucial step in determining the best prognosis. Despite recent advances in the use of AI-based methods, such as machine learning and deep learning (DL), to detect breast cancer, current models are generally limited to simple binary classification of data, rely on a single source of data, and lack transparency, thereby limiting their clinical applicability. To overcome these limitations, we proposed an Explainable Artificial Intelligence (AI)-based Residual Tabular Network (ResTab Net) model based on integrating histopathological images and molecular protein expression data patterns to conduct multimodal BC diagnosis. The proposed model utilizes Adaptive Tissue-Aware Gaussian Filtering (ATGF) to enhance the image, Entropy Enhanced Graph-Watershed Segmentation (EGWS) to clearly define the tumor's location, and Self-Adaptive Starfish Optimization (SASFO) to select the features. A hybrid framework of residual convolutional blocks and dense layers can facilitate successful multiclass classification. To ensure tangible transparency and clinical trust, the model captures SHapley Additive exPlanations (SHAP) and Local Interpretable Model-Agnostic Explanations (LIME) approaches illustrates the impact of molecular protein levels, including image features on classification results. The proposed Explainable AI-ResTab Net model is implemented using Python. The performance evolution of the proposed model achieves an accuracy of 98.56%, a precision of 98.10%, a recall of 98.00%, an F1-score of 98.03%, and an Area Under the Curve (AUC) of 99.60%.
Indexed as
Identifiers
41286231What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.